Lentiviral Transduction and Bioluminescent Imaging
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization :
Other organizations : University of Cambridge, AstraZeneca (United Kingdom), MRC Cancer Unit, Heidelberg University, German Cancer Research Center, University Hospital Regensburg, MRC Laboratory of Molecular Biology, European Bioinformatics Institute
Variable analysis
- Transient co-transfection of 293FT cells with Akaluc-plasmid and the three packaging constructs pMDL, CMV-Rev, and VSV-G
- Bioluminescent signal from B16.F10-Akaluc cells measured at 2, 10, and 30 minutes after i.v. injection into B6.Tyr−/− mice
- Incubation of B16.F10-Akaluc cells with 250 µM Akalumine substrate for 30 minutes at 37 °C in a humidified, 5% CO2 incubator
- Selection of B16.F10 cells with neomycin (Geneticin 1 mg/ml) for 3 days after lentiviral infection
- None specified
- None specified
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!